Kaiji Fan
Regensburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury.
Journal: Signal transduction and targeted therapy
Published: January 25, 2025
Cancer cell reprogramming: turning the enemy into an ally.
Journal: Signal transduction and targeted therapy
Published: November 20, 2024
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration.
Journal: Nature communications
Published: November 19, 2024
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy.
Journal: Cell reports. Medicine
Published: August 31, 2022
B-cell lymphoma-extra large is a promising drug target in Merkel cell carcinoma.
Journal: The British journal of dermatology
Published: August 24, 2022
UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Journal: Journal of cancer research and clinical oncology
Published: December 18, 2019
MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.
Journal: The Journal of investigative dermatology
Published: January 03, 2019
Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.
Journal: The Journal of investigative dermatology
Published: June 12, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 18, 2018
Last Updated: 09/26/2026